TearScience

TearScience develops devices that provide significant clinical identification and treatment of evaporative dry eye.

Funding reportedLast round: Series D

Medical DeviceMorrisville, United States

What company datasets say TearScience raised

Funding, as reported

Reported in all$149Min dollars

Rounds5

Last roundSeries D

Last round dateApr 2016

Investors listed7

SEC Form D$59M sold, 2 filings, last Apr 2016

From the SEC filings it signed: 2 on the team.

On the board, as filediAbhijeet LeleImmanuel ThangarajJoe MandatoJoel CutlerTodd Davis

Investors who name them

Each firm lists TearScience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put TearScience in front of investors. Or tell us what we have wrong.